SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) May 17, 2000
OSTEOTECH, INC.
(Exact name of registrant as specified in its charter)
Delaware 0-19278 13-3357370
(State or other jurisdiction (Commission file Number) (IRS
of incorporation) Identification No.)
51 James Way, Eatontown, New Jersey 07724
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code (732) 542-2800
- --------------------------------------------------------------------------------
(Former name or former address, if changed since last report)
<PAGE>
Item 5. Other Events
On May 17, 2000, Osteotech, Inc. announced that its Board of Directors has
authorized the repurchase and retirement of up to 1 million shares of the
Company's common stock through open market purchases, or block purchases, which
will be made from time to time as market conditions allow. As of April 30, 2000,
there were 14,240,162 shares of common stock outstanding.
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Dated: May 25, 2000
OSTEOTECH, INC.
(Registrant)
By: /s/ Michael J. Jeffries
-------------------------
MICHAEL J. JEFFRIES
Executive Vice President,
Chief Financial Officer
(Principal Financial Officer
and Principal Accounting Officer)
